Bayer Asia PacificLiver Imaging Webinar

Early Diagnosis

Feb22 (thu) 2024 17:30-18:50 (UTC+8)

Role of MRI surveillance in patients with higher HCC risk Role of MRI surveillance in patients with higher HCC risk

Role of MRI surveillance in patients with higher HCC risk

Dr. Dong Hyun Sinn
Hepatologist, South Korea

Diagnosis and management of pre-vascular lesion: impact on treatment choice and patient outcome Diagnosis and management of pre-vascular lesion: impact on treatment choice and patient outcome

Diagnosis and management of pre-vascular lesion: impact on treatment choice and patient outcome

D.r Chien-An Liu
Radiologist, Taiwan

Key Learnings

  • 1. How to increase the accuracy of focal liver lesion characterization and optimize treatment decision.
  • 2. How to improve the comparative effectiveness of HCC surveillance.
Early Diagnosis
Early Diagnosis

This invitation is intended for healthcare professionals only.

Register Here
Register Here

If you would like to register for a webinar, please contact your Bayer representative.

© 2023 Bayer (South East Asia) Pte. Ltd.

Disclaimer: This website is intended to provide information to an international audience outside the USA and UK. Not available in the U.S. and U.K.

  • PP-M_PRI-ALL-0023-1,
  • PP-M_PRI-SG-0009-1(06/24),
  • PP-M_PRI-MY-0004-1(06/24)